Background. Smoking withdrawal and relapse were characterized among newly diagnosed head and neck cancer patients participating in a physician-delivered smoking cessation intervention.Methods. Patients completed questionnaires at baseline, 1, 6, and 12 months following intervention delivery.Results: Significant baseline predictors of smoking relapse included medical treatment (XRT versus surgical treatment), stage of change/readiness to quit (precontemplators), age of initiation (younger), and greater addiction (smoking ഛ30 minutes after waking). Relapsers were significantly more likely to quit using gradual reduction versus cold turkey and had less confidence in remaining quit. Relapsers experienced significantly higher levels of anxiety and craving during withdrawal. Relapse was temporally delayed compared with healthy populations.Conclusion. Assistance with cessation efforts should be ongoing for one year and should include nicotine replacement therapy and psychotropic medications to address significant re- Tobacco is a primary risk factor for head and neck cancers; an estimated 41 400 new cases of cancer of the oral cavity, pharynx and larynx will be diagnosed in 1998 and 12 300 individuals will die from their disease.1,2 Clinicians who treat these tumors are well acquainted with their patients' long and highly addicted history of tobacco use. Our prior research on smoking cessation interventions for this population demonstrated that high quit rates could be obtained, and were sustained over a one-year period. 3,4 In that study, current smokers and recent quitters (individuals who stopped smoking within the year prior to diagnosis), newly diagnosed with first primary squamous cell carcinomas (SCC) of the head and neck, participated in a randomized, controlled
Background Smoking withdrawal and relapse were characterized among newly diagnosed head and neck cancer patients participating in a physician‐delivered smoking cessation intervention. Methods Patients completed questionnaires at baseline, 1, 6, and 12 months following intervention delivery. Results Significant baseline predictors of smoking relapse included medical treatment (XRT versus surgical treatment), stage of change/readiness to quit (precontemplators), age of initiation (younger), and greater addiction (smoking ⩽30 minutes after waking). Relapsers were significantly more likely to quit using gradual reduction versus cold turkey and had less confidence in remaining quit. Relapsers experienced significantly higher levels of anxiety and craving during withdrawal. Relapse was temporally delayed compared with healthy populations. Conclusion Assistance with cessation efforts should be ongoing for one year and should include nicotine replacement therapy and psychotropic medications to address significant relapse triggers. © 1999 John Wiley & Sons, Inc. Head Neck 21: 420–427, 1999.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.